CRS1 Stock Overview
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Ercros, S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.49 |
52 Week High | €4.26 |
52 Week Low | €2.26 |
Beta | 0.87 |
1 Month Change | 2.35% |
3 Month Change | 39.96% |
1 Year Change | -17.90% |
3 Year Change | 31.26% |
5 Year Change | 15.09% |
Change since IPO | -60.87% |
Recent News & Updates
Recent updates
Shareholder Returns
CRS1 | DE Chemicals | DE Market | |
---|---|---|---|
7D | 0.1% | -0.3% | 1.7% |
1Y | -17.9% | -0.3% | 2.3% |
Return vs Industry: CRS1 underperformed the German Chemicals industry which returned 0.2% over the past year.
Return vs Market: CRS1 underperformed the German Market which returned 2.2% over the past year.
Price Volatility
CRS1 volatility | |
---|---|
CRS1 Average Weekly Movement | 10.4% |
Chemicals Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CRS1's share price has been volatile over the past 3 months.
Volatility Over Time: CRS1's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1817 | 1,253 | Antonio Zabalza Marti | www.ercros.es |
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride.
Ercros, S.A. Fundamentals Summary
CRS1 fundamental statistics | |
---|---|
Market cap | €322.77m |
Earnings (TTM) | €28.80m |
Revenue (TTM) | €726.29m |
11.2x
P/E Ratio0.4x
P/S RatioIs CRS1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CRS1 income statement (TTM) | |
---|---|
Revenue | €726.29m |
Cost of Revenue | €519.15m |
Gross Profit | €207.14m |
Other Expenses | €178.34m |
Earnings | €28.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
Earnings per share (EPS) | 0.31 |
Gross Margin | 28.52% |
Net Profit Margin | 3.97% |
Debt/Equity Ratio | 33.6% |
How did CRS1 perform over the long term?
See historical performance and comparison